Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

THPN is an inducer of autophagy and a derivative of gallic acid (Item No. 11846).1 It binds to the ligand-binding domain (LBD) of Nur77 (Kd = 0.27 µM), which increases NIP3L-facilitated translocation of Nur77 to the mitochondria and induces autophagy in A375 melanoma cells. THPN reduces viability of L1210 and CEM leukemia cells (IC50s = 22 and 50 µM, respectively).2 It also reduces cytoplasmic and mitochondrial glutathione levels and increases NF-κB levels in L1210 cells. THPN (20 mg/kg) inhibits the formation of tumors in the lungs and liver in a B16/F10 murine melanoma model.1
WARNING This product is not for human or veterinary use.
1. Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway. Nat. Chem. Biol. 10(2), 133-140 (2014).
2. Ester derivatives of gallic acid with potential toxicity toward L1210 leukemia cells. Bioorg. Med. Chem. 16(7), 3791-3799 (2008).